Invention Publication
- Patent Title: ENGINEERED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF
-
Application No.: US18434220Application Date: 2024-02-06
-
Publication No.: US20240252630A1Publication Date: 2024-08-01
- Inventor: Daniel Getts , Yuxiao Wang , Bruce McCreedy, Jr.
- Applicant: Myeloid Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Myeloid Therapeutics, Inc.
- Current Assignee: Myeloid Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- The original application number of the division: US17590504 2022.02.01
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K9/00 ; A61K9/127 ; A61K9/51 ; A61K38/17 ; A61K48/00 ; A61P35/00
Abstract:
Compositions and methods for making and using engineered cells, such as, engineered myeloid cells that express a chimeric fusion protein that has a binding domain capable to binding surface molecules on target cells such as diseased cells.
Information query
